These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3029471)

  • 21. [Hepatocellular cancer with a background of liver cirrhosis].
    Zhuravlev VA; Agalakov VI
    Klin Med (Mosk); 1996; 74(2):2-5. PubMed ID: 8772088
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatic cirrhosis with and without implanted carcinoma. Apropos of 100 cases with necropsy].
    Pérez Flores R; Cortés Cansino J; Oliva Aldamiz H; Hernández Guío C
    Rev Clin Esp; 1987 Nov; 181(7):356-60. PubMed ID: 2827249
    [No Abstract]   [Full Text] [Related]  

  • 23. [Primary cancer of the liver superimposed upon cirrhosis].
    Caroli J; Marcus N; Grynblat A; Chevrel B
    Rev Med Chir Mal Foie; 1970; 45(6):291-8. PubMed ID: 4322956
    [No Abstract]   [Full Text] [Related]  

  • 24. Surveillance for hepatocellular carcinoma in cirrhosis: is it cost-effective?
    Farinati F; Gianni S
    Eur J Cancer Prev; 2001 Feb; 10(1):111-5. PubMed ID: 11263586
    [No Abstract]   [Full Text] [Related]  

  • 25. Surveillance of Indians with liver cirrhosis for treatable hepatocellular carcinoma: another enigma.
    Mohandas KM
    Indian J Gastroenterol; 2007; 26(6):261-4. PubMed ID: 18431007
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of tumor factors on the prognosis of patients with advanced cirrhosis (Child-Pugh class C) and hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Hayashi K; Honda T; Kuzuya T; Nonogaki K; Shimizu J
    J Gastroenterol Hepatol; 2005 Jun; 20(6):963-5. PubMed ID: 15946154
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis.
    Borzio M; Trerè D; Borzio F; Ferrari AR; Bruno S; Roncalli M; Colloredo G; Leandro G; Oliveri F; Derenzini M
    Mol Pathol; 1998 Apr; 51(2):96-101. PubMed ID: 9713593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors in development of liver carcinoma in cirrhosis.
    Bjørneboe M
    Lancet; 1985 Sep; 2(8455):611-2. PubMed ID: 2863618
    [No Abstract]   [Full Text] [Related]  

  • 29. Unexpected characteristics of cirrhotic liver tumors.
    Kwiecień K; Musialik J; Król R; Kwaśniewska A; Paleń P; Więcek A
    Pol Arch Intern Med; 2018 Mar; 128(3):187-188. PubMed ID: 29579034
    [No Abstract]   [Full Text] [Related]  

  • 30. Is the incidence of intrahepatic multicentric recurrence of hepatocellular carcinoma more frequent in "the carcinogenic stage" than in liver cirrhosis?
    Izumi N
    J Gastroenterol; 2003; 38(9):918-20. PubMed ID: 14564643
    [No Abstract]   [Full Text] [Related]  

  • 31. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Surgical treatment of hepatoma in liver cirrhosis].
    Launois B; Bourdonnec P; Nguyen T; Deugnier Y; Campion JP; Cardin JL; Nicolas JC
    Chirurgie; 1987; 113(3):252-7. PubMed ID: 2820662
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatocellular carcinoma in childhood.
    McDougal RA
    Arch Pathol Lab Med; 1979 Aug; 103(9):489. PubMed ID: 223521
    [No Abstract]   [Full Text] [Related]  

  • 34. Viral hepatitis, postnecrotic cirrhosis, and hepatocellular carcinoma.
    Smith JB; Blumberg BS
    Lancet; 1969 Nov; 2(7627):953. PubMed ID: 4186610
    [No Abstract]   [Full Text] [Related]  

  • 35. Prediction of hepatocellular carcinoma: using a complex risk model or assisting for smoking cessation?
    Braillon A
    Cancer; 2015 Apr; 121(7):1149-50. PubMed ID: 25470258
    [No Abstract]   [Full Text] [Related]  

  • 36. [What is the value of systematic screening of hepatocellular carcinomas in patients with liver cirrhosis?].
    Pateron D
    Gastroenterol Clin Biol; 1992; 16(11):908-9. PubMed ID: 1336468
    [No Abstract]   [Full Text] [Related]  

  • 37. Reply to Prediction of hepatocellular carcinoma: using a complex risk model or assisting for smoking cessation?
    Flemming JA; Kim WR; Terrault NA
    Cancer; 2015 Apr; 121(7):1150. PubMed ID: 25470366
    [No Abstract]   [Full Text] [Related]  

  • 38. Merging epidemiological changes and surveillance data to optimize management of hepatocellular carcinoma.
    Cillo U
    Dig Liver Dis; 2011 Nov; 43(11):841-2. PubMed ID: 21908240
    [No Abstract]   [Full Text] [Related]  

  • 39. [Role of combined etiology (alcohol and B virus) in the development of hepatocarcinoma in subjects with liver cirrhosis].
    Cristani A; Pentore R; Cioni G; Mussini C; Grandi S; Ventura E
    Recenti Prog Med; 1989 May; 80(5):233-6. PubMed ID: 2548264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of Biermer's anemia with liver cirrhosis (development followed for 14 years, death due to hepatocarcinoma)].
    Olmer J; Moutaffian JJ
    Mars Med; 1969; 106(4):345-8. PubMed ID: 4315575
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.